Whipple's triad

From WikiMD's WELLNESSPEDIA


Whipple's triad
Synonyms
Pronounce N/A
Specialty N/A
Symptoms Hypoglycemia, neuroglycopenia, relief of symptoms after glucose administration
Complications
Onset
Duration
Types
Causes Insulinoma, insulin overdose, non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS)
Risks
Diagnosis Clinical evaluation, blood glucose measurement
Differential diagnosis
Prevention
Treatment Glucose administration, treatment of underlying cause
Medication
Prognosis
Frequency
Deaths


Whipple's triad is a collection of three criteria that suggest a patient's symptoms result from hypoglycemia caused by an insulinoma, a type of pancreatic tumor. The triad was named after Allen Whipple, an American surgeon who first described the condition in 1938.

Criteria[edit]

The three criteria of Whipple's triad are:

  1. Symptoms consistent with hypoglycemia
  2. Low plasma glucose at the time of symptoms
  3. Relief of symptoms when glucose levels are raised

Symptoms[edit]

Symptoms of hypoglycemia can vary from person to person, but often include:

Diagnosis[edit]

Whipple's triad is often used as a diagnostic tool in the evaluation of patients with suspected insulinoma. However, it is not definitive proof of the condition. Further tests, such as a fasting test or imaging studies, may be required to confirm the diagnosis.

Treatment[edit]

Treatment for insulinoma typically involves surgical removal of the tumor. In some cases, medication may be used to manage symptoms until surgery can be performed.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.